201 related articles for article (PubMed ID: 14574451)
1. Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.
Queen LR; Ji Y; Goubareva I; Ferro A
Diabetologia; 2003 Nov; 46(11):1474-82. PubMed ID: 14574451
[TBL] [Abstract][Full Text] [Related]
2. beta(2)-adrenoceptors activate nitric oxide synthase in human platelets.
Queen LR; Xu B; Horinouchi K; Fisher I; Ferro A
Circ Res; 2000 Jul; 87(1):39-44. PubMed ID: 10884370
[TBL] [Abstract][Full Text] [Related]
3. Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production.
Schaeffer G; Wascher TC; Kostner GM; Graier WF
Diabetologia; 1999 Feb; 42(2):167-76. PubMed ID: 10064096
[TBL] [Abstract][Full Text] [Related]
4. Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus.
Milsom AB; Jones CJ; Goodfellow J; Frenneaux MP; Peters JR; James PE
Diabetologia; 2002 Nov; 45(11):1515-22. PubMed ID: 12436334
[TBL] [Abstract][Full Text] [Related]
5. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
[TBL] [Abstract][Full Text] [Related]
6. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski MW; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease.
Riddell DR; Graham A; Owen JS
J Biol Chem; 1997 Jan; 272(1):89-95. PubMed ID: 8995232
[TBL] [Abstract][Full Text] [Related]
8. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
9. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets.
Tannous M; Rabini RA; Vignini A; Moretti N; Fumelli P; Zielinski B; Mazzanti L; Mutus B
Diabetologia; 1999 May; 42(5):539-44. PubMed ID: 10333045
[TBL] [Abstract][Full Text] [Related]
10. The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide.
Trovati M; Massucco P; Mattiello L; Piretto V; Cavalot F; Mularoni E; Anfossi G
Diabetes; 1996 Jun; 45(6):768-70. PubMed ID: 8635651
[TBL] [Abstract][Full Text] [Related]
11. Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients.
da Silva CD; Brunini TM; Reis PF; Moss MB; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
Kidney Int; 2005 Nov; 68(5):2173-9. PubMed ID: 16221216
[TBL] [Abstract][Full Text] [Related]
12. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro.
Ferro A; Queen LR; Priest RM; Xu B; Ritter JM; Poston L; Ward JP
Br J Pharmacol; 1999 Apr; 126(8):1872-80. PubMed ID: 10372832
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.
Mutus B; Rabini RA; Staffolani R; Ricciotti R; Fumelli P; Moretti N; Martarelli D; Mazzanti L
Diabetologia; 2001 Aug; 44(8):979-82. PubMed ID: 11484074
[TBL] [Abstract][Full Text] [Related]
14. Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment.
O'Kane PD; Queen LR; Ji Y; Reebye V; Stratton P; Jackson G; Ferro A
Cardiovasc Res; 2003 Jul; 59(1):152-9. PubMed ID: 12829186
[TBL] [Abstract][Full Text] [Related]
15. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function.
Chen LY; Mehta P; Mehta JL
Circulation; 1996 May; 93(9):1740-6. PubMed ID: 8653881
[TBL] [Abstract][Full Text] [Related]
16. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2.
Banerjee D; Mazumder S; Sinha AK
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):585-91. PubMed ID: 25083729
[TBL] [Abstract][Full Text] [Related]
17. Low plasma levels of L-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients.
Pinto VL; de Souza PF; Brunini TM; Oliveira MB; Moss MB; Siqueira MA; Ferraz MR; Mendes-Ribeiro AC
J Affect Disord; 2012 Oct; 140(2):187-92. PubMed ID: 22424639
[TBL] [Abstract][Full Text] [Related]
18. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate.
Trovati M; Anfossi G; Massucco P; Mattiello L; Costamagna C; Piretto V; Mularoni E; Cavalot F; Bosia A; Ghigo D
Diabetes; 1997 May; 46(5):742-9. PubMed ID: 9133539
[TBL] [Abstract][Full Text] [Related]
19. Platelet hyperaggregability in obesity: is there a role for nitric oxide impairment and oxidative stress?
Leite NR; Siqueira de Medeiros M; Mury WV; Matsuura C; Perszel MB; Noronha Filho G; Brunini TM; Mendes-Ribeiro AC
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):738-44. PubMed ID: 27145241
[TBL] [Abstract][Full Text] [Related]
20. Platelet nitric oxide signalling in heart failure: role of oxidative stress.
Shah A; Passacquale G; Gkaliagkousi E; Ritter J; Ferro A
Cardiovasc Res; 2011 Sep; 91(4):625-31. PubMed ID: 21502370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
